Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khazenzon, N. M.
Right arrow Articles by Ljubimova, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khazenzon, N. M.
Right arrow Articles by Ljubimova, J. Y.
Mol Cancer Ther. 2003;2:985-994
© 2003 American Association for Cancer Research

Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro

Natalya M. Khazenzon1, Alexander V. Ljubimov2, Alexander J. Lakhter1, Manabu Fujita1, Hironobu Fujiwara3, Kiyotoshi Sekiguchi3, Lydia M. Sorokin4, Noora Petäjäniemi5, Ismo Virtanen5, Keith L. Black1 and Julia Y. Ljubimova1

1 Maxine Dunitz Neurosurgical Institute and 2 Ophthalmology Research Laboratories, Cedars-Sinai Medical Center, Los Angeles, CA; 3 Institute for Protein Research, Osaka University, Osaka, Japan; 4 Department of Pathology, Jubileum Institute, Lund University, Lund, Sweden; 5 Institute of Biomedicine/Anatomy, University of Helsinki, Helsinki, Finland

Requests for reprints: Julia Y. Ljubimova, Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, 8631 West Third Street, Suite 800-E, Los Angeles, CA 90048. Phone: (310) 423-0834; Fax: (310) 423-0810. E-mail: ljubimovaj{at}cshs.org

Using gene array technology, we recently observed for the first time an up-regulation of laminin {alpha}4 chain in human gliomas. The data were validated by semiquantitative reverse transcription-PCR for RNA expression and immunohistochemistry for protein expression. Moreover, increase of the {alpha}4 chain-containing laminin-8 correlated with poor prognosis for patients with brain gliomas. Therefore, we hypothesized that inhibition of laminin-8 expression by a new generation of highly specific and stable antisense oligonucleotides (Morpholino) against chains of laminin-8 could slow or stop the spread of glioma and its recurrence and thus might be a promising approach for glioma therapy. We next sought to establish an in vitro model to test the feasibility of this approach and to optimize conditions for Morpholino treatment. To develop a model, we used human glioblastoma multiforme cell lines M059K and U-87MG cocultured with normal human brain microvascular endothelial cells (HBMVEC). Using Western blot analysis and immunohistochemistry, we confirmed that antisense treatment effectively blocked laminin-8 protein synthesis. Antisense oligonucleotides against both {alpha}4 and ß1 chains of laminin-8 were able to block significantly the invasion of cocultures through Matrigel. On average, the invasion was blocked by 62% in cocultures of U-87MG with HBMVEC and by 53% in cocultures of M059K with HBMVEC. The results show that laminin-8 may contribute to glioma progression and recurrence not only as part of the neovascularization process but also by directly increasing the invasive potential of tumor cells.


The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Grant support: Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, and Arrogene, Inc.

2 American Cancer Society, Brain and Spinal Cord Tumors in Adults (http://www.cancer.org/eprise/main/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_brain_and_spinal_cord_tumors_3?sitearea=C. RI).

Received 1/10/03; revised 6/18/03; accepted 7/22/03.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
A. K. Berfield, K. M. Hansen, and C. K. Abrass
Rat glomerular mesangial cells require laminin-9 to migrate in response to insulin-like growth factor binding protein-5
Am J Physiol Cell Physiol, October 1, 2006; 291(4): C589 - C599.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Saghizadeh, A. A. Kramerov, J. Tajbakhsh, A. M. Aoki, C. Wang, N.-N. Chai, J. Y. Ljubimova, T. Sasaki, G. Sosne, M. R. J. Carlson, et al.
Proteinase and Growth Factor Alterations Revealed by Gene Microarray Analysis of Human Diabetic Corneas
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3604 - 3615.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Maatta, R. Butzow, J. Luostarinen, N. Petajaniemi, T. Pihlajaniemi, S. Salo, K. Miyazaki, H. Autio-Harmainen, and I. Virtanen
Differential Expression of Laminin Isoforms in Ovarian Epithelial Carcinomas Suggesting Different Origin and Providing Tools for Differential Diagnosis
J. Histochem. Cytochem., October 1, 2005; 53(10): 1293 - 1300.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.